Literature DB >> 26225198

Impairment of aspirin antiplatelet effects by non-opioid analgesic medication.

Amin Polzin1, Thomas Hohlfeld1, Malte Kelm1, Tobias Zeus1.   

Abstract

Aspirin is the mainstay in prophylaxis of cardiovascular diseases. Impaired aspirin antiplatelet effects are associated with enhanced incidence of cardiovascular events. Comedication with non-opioid analgesic drugs has been described to interfere with aspirin, resulting in impaired aspirin antiplatelet effects. Additionally, non-opioid analgesic medication has been shown to enhance the risk of cardiovascular events and death. Pain is very frequent and many patients rely on analgesic drugs to control pain. Therefore effective analgesic options without increased risk of cardiovascular events are desirable. This review focuses on commonly used non-opioid analgesics, interactions with aspirin medication and impact on cardiovascular risk.

Entities:  

Keywords:  Aspirin; Dipyrone; Drug-drug interaction; Metamizole; Non-steroidal anti-inflammatory drug; Paracetamol; Pharmacodynamic

Year:  2015        PMID: 26225198      PMCID: PMC4513489          DOI: 10.4330/wjc.v7.i7.383

Source DB:  PubMed          Journal:  World J Cardiol


  98 in total

1.  Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.

Authors:  Robert S Bresalier; Robert S Sandler; Hui Quan; James A Bolognese; Bettina Oxenius; Kevin Horgan; Christopher Lines; Robert Riddell; Dion Morton; Angel Lanas; Marvin A Konstam; John A Baron
Journal:  N Engl J Med       Date:  2005-02-15       Impact factor: 91.245

2.  Nonnarcotic analgesic use and the risk of hypertension in US women.

Authors:  Julien Dedier; Meir J Stampfer; Susan E Hankinson; Walter C Willett; Frank E Speizer; Gary C Curhan
Journal:  Hypertension       Date:  2002-11       Impact factor: 10.190

3.  The history and usage of paracetamol.

Authors:  J B Spooner; J G Harvey
Journal:  J Int Med Res       Date:  1976       Impact factor: 1.671

4.  Chronic pain in the Republic of Ireland--community prevalence, psychosocial profile and predictors of pain-related disability: results from the Prevalence, Impact and Cost of Chronic Pain (PRIME) study, part 1.

Authors:  Miriam N Raftery; Kiran Sarma; Andrew W Murphy; Davida De la Harpe; Charles Normand; Brian E McGuire
Journal:  Pain       Date:  2011-03-29       Impact factor: 6.961

5.  Dose-dependent inhibition of platelet function by acetaminophen in healthy volunteers.

Authors:  Edward Munsterhjelm; Nina M Munsterhjelm; Tomi T Niemi; Olavi Ylikorkala; Pertti J Neuvonen; Per H Rosenberg
Journal:  Anesthesiology       Date:  2005-10       Impact factor: 7.892

6.  Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism.

Authors:  Gisèle Pickering; Marie-Anne Loriot; Frédéric Libert; Alain Eschalier; Philippe Beaune; Claude Dubray
Journal:  Clin Pharmacol Ther       Date:  2006-04       Impact factor: 6.875

Review 7.  Acetaminophen hepatotoxicity.

Authors:  M Black
Journal:  Annu Rev Med       Date:  1984       Impact factor: 13.739

Review 8.  Update on ibuprofen: review article.

Authors:  M Busson
Journal:  J Int Med Res       Date:  1986       Impact factor: 1.671

Review 9.  Myocardial infarction in young people.

Authors:  Ewa Trzos; Barbara Uznańska; Tomasz Rechciński; Maria Krzemińska-Pakuła; Magdalena Bugała; Małgorzata Kurpesa
Journal:  Cardiol J       Date:  2009       Impact factor: 2.737

Review 10.  Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies.

Authors:  Patricia McGettigan; David Henry
Journal:  PLoS Med       Date:  2011-09-27       Impact factor: 11.069

View more
  2 in total

1.  The Role of Cyclooxygenase Enzymes in the Effects of Losartan and Lisinopril on the Contractions of Rat Thoracic Aorta.

Authors:  Fikriye Yasemin Ozatik; Bilgin Kaygisiz; Kevser Erol
Journal:  Eurasian J Med       Date:  2017-02

2.  Excess Mortality in Aspirin and Dipyrone (Metamizole) Co-Medicated in Patients With Cardiovascular Disease: A Nationwide Study.

Authors:  Amin Polzin; Lisa Dannenberg; Carolin Helten; Martin Pöhl; Daniel Metzen; Philipp Mourikis; Christof Dücker; Ursula Marschall; Helmut L'Hoest; Beata Hennig; Saif Zako; Kajetan Trojovsky; Tobias Petzold; Christian Jung; Bodo Levkau; Tobias Zeus; Karsten Schrör; Thomas Hohlfeld; Malte Kelm
Journal:  J Am Heart Assoc       Date:  2021-11-02       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.